Clontech Laboratories, Inc. Licenses CRISPR/Cas9 Technology From The Broad Institute

"Clontech is pleased to be able to provide innovative tools for CRISPR/Cas9 gene editing under our Guide-it brand," commented , General Manager of Clontech Laboratories, Inc. "We believe that CRISPR/Cas9 technology represents a significant improvement over existing genome editing tools, reaching a new level of targeting, efficiency, and in particular ease of use. It is destined to become as valuable and widely utilized as RNAi; perhaps more so."

http://www.biospace.com/news_story.aspx?StoryID=351639&full=1